礼来 Concord 注射剂基地获 2026 年 ISPE 年度设施奖运营—项目执行类别奖
走进礼来 2026 年 ISPE 年度设施奖(FOYA)“运营—项目执行”类别获奖项目:Lilly Concord
礼来位于美国北卡罗来纳州 Concord 的注射剂生产基地获得 2026 年 ISPE 年度设施奖(FOYA)运营—项目执行类别奖,该园区从 2022 年 6 月破土动工到 2024 年 12 月获 FDA 批准,历时 30 个月。
Inside Eli Lilly and Company's 2026 ISPE Facility of the Year Awards (FOYA) Operations – Project Execution Category Award-Winning Project: Lilly Concord
来源 / Source:ISPE Pharmaceutical Engineering / iSpeak Blog(国际制药工程协会)
URL:https://ispe.org/pharmaceutical-engineering/ispeak/inside-eli-lilly-and-companys-2026-ispe-facility-year-awards-foya
发布日期 / Published:2026-09-17
主体 / Subject:礼来公司(Eli Lilly and Company)北卡罗来纳州 Concord 制造基地(Lilly Concord)
配套来源 / Companion source:FOYA 获奖页《2026 ISPE Facility of the Year Awards Category Winner for Operations – Project Execution》(https://ispe.org/facility-year-awards/winners/2026/operations-project-execution )。
图注:Lilly Concord 园区航拍,110 万平方英尺、11 栋建筑、75 英亩场地。(图源:ispewebassets.org)
Eli Lilly and Company's Lilly Concord manufacturing facility is redefining what is possible in pharmaceutical project delivery. Recognized with the 2026 ISPE Facility of the Year Awards (FOYA) Operations – Project Execution Category Award, the North Carolina site demonstrates how innovative execution strategies, advanced digital technologies, and disciplined governance can dramatically accelerate the delivery of complex pharmaceutical manufacturing capacity without compromising quality, compliance, or operational readiness.
礼来公司的 Lilly Concord 制造设施正在重新界定制药项目交付的边界。该北卡罗来纳州基地获得了 2026 年 ISPE 年度设施奖(FOYA)“运营—项目执行”类别奖,它展示了创新的执行策略、先进的数字技术与有纪律的治理,如何在不动摇质量、合规与运营就绪度的前提下,大幅加快复杂制药产能的交付。
Located in Concord, North Carolina, USA, the 1.1 million-square-foot campus spans 11 buildings across a 75-acre site and serves as a critical component of Lilly's strategy to expand global manufacturing capacity for high-demand injectable therapies. The facility was designed to fill and inspect prefilled syringes and assemble and package auto-injector devices, helping address rapidly growing patient demand for incretin medicines and other injectable treatments.
该园区位于美国北卡罗来纳州 Concord,建筑面积 110 万平方英尺,由 11 栋建筑组成,占地 75 英亩,是礼来扩大高需求注射疗法全球产能战略的重要组成部分。设施用于预灌封注射器的灌装与检验,以及自动注射器器械的组装与包装,以应对患者对肠促胰素类药物及其他注射治疗快速增长的需求。
What makes the project particularly remarkable is its execution timeline. While pharmaceutical manufacturing facilities often require five to 10 years to progress from concept to validated production, Lilly Concord achieved the journey from groundbreaking on a greenfield site to first validated production runs in just 30 months. This exceptional performance earned the facility recognition for project execution excellence and established a new benchmark for future pharmaceutical manufacturing projects.
这个项目尤为突出之处在于其执行工期。制药生产设施从概念到验证生产,往往需要五到十年;而 Lilly Concord 在一块绿地上从破土动工到首批验证生产运行,只用了 30 个月。这一表现让该设施获得了项目执行卓越方面的认可,并为未来的制药生产项目立下了一个新基准。
一、礼来为何获奖
Why Lilly Won
Delivering pharmaceutical manufacturing facilities has traditionally been a lengthy, sequential process involving design, site preparation, construction, equipment installation, commissioning, qualification, and validation. For products experiencing rapidly increasing global demand, however, conventional timelines can create significant challenges.
交付制药生产设施传统上是一个漫长的串行过程,包括设计、场地准备、施工、设备安装、调试、确认与验证。然而,对于全球需求快速攀升的产品,常规工期会带来重大挑战。
Faced with the need to expand manufacturing capacity for complex injectable therapies, Lilly adopted a fundamentally different approach to project delivery. The company combined parallel execution strategies, modular construction, replication of proven facility platforms, digital twin technologies, and structured governance models to accelerate every phase of the project while maintaining strict quality and regulatory standards.
面对扩大复杂注射疗法产能的需要,礼来在项目交付上采取了根本不同的做法。公司把并行执行策略、模块化建造、成熟设施平台的复制、数字孪生技术以及结构化的治理模式组合起来,在维持严格的质量与法规标准的同时,加速项目的每一个阶段。
The result was a US Food and Drug Administration-approved parenteral manufacturing facility delivered in less than three years, substantially faster than industry norms. Through extensive offsite fabrication, virtual validation activities, and standardized facility designs, Lilly reduced risk, compressed schedules, and improved startup readiness while creating a model that can be replicated across future projects.
结果是一座获得美国食品药品监督管理局批准的注射剂生产设施,在不到三年内交付,显著快于行业常规。通过大量场外预制、虚拟验证活动与标准化设施设计,礼来降低了风险、压缩了工期、提升了开车就绪度,同时形成了一个可在未来项目中复制的模型。
As Dan VonDielingen, Senior Vice President, Global Parenteral Network Expansion, Eli Lilly and Company, explained, "Since bringing Lilly Concord online—drawing on proven models from our Lilly Research Triangle Park facility—we have continued to expand its capabilities in step with growing demand for our medicines. Lilly's investment in the Charlotte and Concord region is a long-term commitment to expanding US manufacturing capacity and strengthening the supply chain that gets medicines to people who need them."
礼来公司全球注射剂网络扩建高级副总裁 Dan VonDielingen 解释道:“自 Lilly Concord 投产以来——借助我们 Lilly Research Triangle Park 设施的成熟模型——我们一直在随着药品需求的增长同步扩展其能力。礼来在夏洛特与 Concord 地区的投资,是一项扩大美国制造产能、强化把药品送到需要者手中这条供应链的长期承诺。”
图注:Lilly Concord 主楼外观,外立面为礼来标识。(图源:ispewebassets.org)
二、为规模而建的注射剂设施
A Parenteral Facility Built for Scale
The Lilly Concord project leveraged the successful design framework established at Lilly's Research Triangle Park (RTP) facility in North Carolina while incorporating targeted enhancements to address site-specific requirements and operational goals.
Lilly Concord 项目沿用了礼来北卡罗来纳州 Research Triangle Park(RTP)设施已确立的成功设计框架,同时做了有针对性的增强,以对应本场地的具体要求与运营目标。
Rather than developing entirely new facility and equipment concepts, the project team applied existing validated designs, standardized layouts, automation templates, and proven manufacturing systems. This approach reduced engineering effort, minimized design risks, and accelerated equipment procurement and qualification activities.
项目团队没有去开发全新的设施与设备构想,而是沿用已有的验证过的设计、标准化布局、自动化模板与成熟的制造系统。这一做法减少了工程投入、把设计风险压到最低,并加快了设备采购与确认活动。
The resulting facility combines modern automation, paperless operations, digitalized workflows, and scalable manufacturing infrastructure to support long-term growth. Designed with future expansion in mind, the site strengthens Lilly's ability to meet increasing patient demand while improving supply chain resilience.
由此建成的设施把现代自动化、无纸化运营、数字化工作流与可扩展的制造基础设施结合在一起,以支撑长期增长。该场地在设计时即考虑了未来扩建,增强了礼来满足不断上升的患者需求的能力,同时提升了供应链韧性。
图注:厂房内的自动化物料搬运与输送系统,对应五大工作流中的物流与器械组装包装环节。(图源:ispewebassets.org)
三、设计—建造并行推进加快了交付
Parallel Design-Build Execution Accelerated Delivery
One of the primary drivers behind the project's speed was an innovative Cold Dark Shell execution strategy.
支撑项目速度的主要因素之一,是一项名为 Cold Dark Shell 的创新执行策略。
Traditionally, pharmaceutical construction projects follow a largely sequential process in which building completion precedes interior design and fit-out activities. At Concord, Lilly advanced construction of foundations, building envelopes, and major utility distribution systems before finalizing portions of the interior design. This allowed multiple project activities to proceed simultaneously rather than sequentially.
传统上,制药建设项目大体遵循串行流程:建筑完工先于内部设计与内装。在 Concord,礼来先推进地基、建筑外壳与主要公用工程分配系统的施工,之后才最终确定部分内部设计。这让多项项目活动得以同时推进,而不是依次进行。
The approach reduced the project schedule by nearly six months while preserving quality and regulatory compliance requirements.
该做法把项目工期缩短了近六个月,同时守住了质量与法规合规要求。
To coordinate this accelerated delivery model, Lilly implemented a centralized governance structure overseeing five major workstreams:
为协调这一加速交付模式,礼来实施了一套集中式治理架构,统辖五大工作流:
· Site development
· Logistics
· Parenteral manufacturing operations
· Device assembly and packaging
· Administrative and laboratory spaces
· 场地开发
· 物流
· 注射剂生产运营
· 设备组装与包装
· 行政与实验室空间
This governance framework empowered rapid decision-making, streamlined issue resolution, and ensured alignment between construction milestones and operational readiness objectives.
这一治理框架支撑了快速决策、精简了问题解决流程,并确保施工节点与运营就绪目标之间保持一致。
四、复制成熟平台降低了风险
Replicating a Proven Platform Reduced Risk
Another key contributor to project success was Lilly's decision to replicate and enhance proven facility designs from its RTP manufacturing site.
项目成功的另一个关键因素,是礼来决定复制并增强其 RTP 生产基地已获验证的设施设计。
Rather than creating entirely new systems, the Concord team adopted established equipment configurations, automation platforms, and facility layouts that had already demonstrated successful performance. Targeted improvements were incorporated where appropriate, but the core architecture remained consistent.
Concord 团队没有另起炉灶造全新系统,而是采用已被证明运行成功的既有设备配置、自动化平台与设施布局。在合适之处做了有针对性的改进,但核心架构保持一致。
This strategy delivered several advantages:
该策略带来了若干好处:
· Reduced engineering and design effort
· Eliminated significant equipment development time
· Minimized long-lead procurement risks
· Simplified qualification activities
· Streamlined manufacturing execution system integration
· Accelerated commissioning and startup
· 减少工程与设计投入
· 省去大量设备开发时间
· 把长交期采购风险降到最低
· 简化确认活动
· 理顺制造执行系统集成
· 加快调试与开车
Because many systems had already been validated and proven in operation, the project team was able to focus resources on execution rather than redesign, significantly reducing project risk.
由于许多系统已经过验证并在运行中得到证明,项目团队得以把资源集中在执行上而非重新设计,从而显著降低了项目风险。
五、模块化建造提升了效率
Modular Construction Improved Efficiency
Modularization played a central role in accelerating installation and commissioning activities.
模块化在加快安装与调试活动方面起到了核心作用。
A standout example was the facility's 14,000-square-foot Central Utility Plant (CUP). Rather than building the plant entirely onsite, Lilly designed and fabricated 25 individual modules offsite in South Carolina. The modules underwent partial testing before being transported to Concord for final assembly and integration.
一个突出例子是设施 14,000 平方英尺的中央公用工程站(CUP)。礼来没有完全在现场建造,而是在南卡罗来纳州设计并预制了 25 个独立模块。这些模块经部分测试后运至 Concord 做最终组装与集成。
This strategy enabled construction and fabrication activities to occur in parallel, improved quality through controlled manufacturing environments, and reduced onsite labor congestion.
这一策略让施工与预制活动得以并行,通过受控的制造环境提升了质量,并减少了现场的人力拥挤。
Modular utility systems also facilitated faster commissioning and created a repeatable model for future Lilly facilities. By relocating substantial portions of construction away from the project site, teams were able to improve schedule certainty while maintaining high installation standards.
模块化公用工程系统还促成了更快的调试,并为礼来未来的设施创造了一个可复制的模型。通过把相当大一部分建造工作移出项目现场,团队在维持高安装标准的同时提升了工期确定性。
图注:预灌封注射器灌装线所在的隔离器,操作口配蓝色手套。(图源:ispewebassets.org)
六、数字孪生技术改变了验证方式
Digital Twin Technology Transformed Validation
Among the project's most innovative features was its extensive use of digital twin technology and virtual commissioning tools.
项目最具创新性的特点之一,是大量使用数字孪生技术与虚拟调试工具。
Before physical equipment arrived onsite, Lilly developed a high-fidelity virtual model representing the complete manufacturing ecosystem. The digital environment included:
在实体设备到场之前,礼来就开发了一个高保真虚拟模型,代表完整的制造生态。该数字环境包括:
· Prefilled syringe filling lines
· Formulation systems
· Clean utility systems
· Autoclaves
· Part washers
· 预灌封注射器灌装线
· 配制系统
· 洁净公用工程系统
· 灭菌柜
· 部件清洗机
This virtual facility enabled teams to test automation logic, validate startup sequences, verify alarms and interlocks, and assess human-machine interface functionality months before installation.
这个虚拟设施让团队能够在设备安装前几个月,就测试自动化逻辑、验证开车顺序、核对报警与联锁,并评估人机界面功能。
More than 250 days of virtual testing were completed, reducing floor-based testing requirements by approximately 50 percent. The approach accelerated commissioning and qualification activities while improving safety, compliance, and operational readiness.
共完成 250 天以上的虚拟测试,使现场实测需求减少约 50%。该做法加快了调试与确认活动,同时提升了安全性、合规性与运营就绪度。
By identifying and resolving issues in a digital environment rather than during startup, Lilly significantly reduced execution risk and established a scalable framework for future pharmaceutical facility deployments.
通过在数字环境中而非开车阶段发现并解决问题,礼来显著降低了执行风险,并为未来的制药设施部署建立了一个可扩展的框架。
图注:洁净区内的物料搬运通道与转运设备。(图源:ispewebassets.org)
七、快速满足患者需求
Rapidly Meeting Patient Needs
The Lilly Concord facility demonstrates how advanced manufacturing technologies, digitalization, and innovative project delivery strategies can dramatically improve the speed at which pharmaceutical capacity becomes available to patients.
Lilly Concord 设施展示了先进的制造技术、数字化与创新的项目交付策略,如何大幅提升制药产能对患者可用的速度。
Most importantly, the project addresses a critical industry challenge: rapidly increasing demand for essential medicines. By reducing facility delivery timelines while maintaining quality and compliance standards, Lilly has created a blueprint for future manufacturing expansions that can help alleviate supply constraints and improve patient access.
最重要的是,该项目回应了行业的一个关键挑战:基本药物需求的快速上升。通过在维持质量与合规标准的同时压缩设施交付工期,礼来为未来的产能扩建给出了一份蓝图,有助于缓解供应约束、改善患者可及性。
The facility stands as an example of how paperless operations, automation, modular construction, digital twins, and platform replication can work together to transform pharmaceutical project execution.
该设施是这样一个例子:无纸化运营、自动化、模块化建造、数字孪生与平台复制可以协同作用,改变制药项目的执行方式。
"Strong partnerships with state and local governments, universities, and economic development organizations remain central to our success here," VonDielingen noted. "Both Concord and our RTP site are built to scale with us and we remain committed to growing alongside the communities that have made them possible."
“与州及地方政府、高校和经济发展机构的紧密合作,仍是我们在这里取得成功的关键,”VonDielingen 指出。“Concord 与我们的 RTP 基地都按可随我们一同扩展的方式建设,我们也依然致力于与成就了它们的社区共同成长。”
Through Lilly Concord, Eli Lilly and Company has demonstrated that pharmaceutical facilities no longer need to follow traditional development timelines. By combining proven design platforms with innovative execution strategies and advanced digital technologies, the company has established a new benchmark for project delivery speed, operational readiness, and manufacturing scalability. The project's success provides a compelling model for future facilities seeking to bring life-changing medicines to patients faster than ever before.
通过 Lilly Concord,礼来公司证明了制药设施不再必须遵循传统的开发工期。公司把成熟的设计平台与创新执行策略和先进数字技术结合起来,为项目交付速度、运营就绪度与制造可扩展性建立了一个新基准。该项目的成功,为那些希望比以往任何时候都更快地把改变生命的药品带给患者的未来设施,提供了一个有说服力的模型。
八、附录:FOYA 获奖页给出的指标
Appendix: Metrics from the FOYA winner page
As a fully paperless, automated parenteral manufacturing campus constructed on 415 acres of greenfield land, the facility progressed from groundbreaking in June 2022 to US Food and Drug Administration approval in December 2024—in 30 months, an execution timeline far below industry norms.
作为一座建在 415 英亩绿地上的全无纸化、自动化注射剂生产园区,该设施从 2022 年 6 月破土动工到 2024 年 12 月获美国食品药品监督管理局批准,历时 30 个月,远低于行业常规工期。
Five autonomous workstreams—site development, logistics, parenteral operations, device assembly, and administrative/lab spaces—operated with empowered decision making.
五大自主工作流——场地开发、物流、注射剂运营、器械组装、行政与实验室空间——在获得授权的决策机制下运行。
Leveraging pre qualified automation templates, standardized layouts, and harmonized equipment platforms reduced testing durations and enabled the site to reach first device assembly operations three to four months earlier and first syringe filling capability more than a year ahead of comparable deployments.
借助预先确认的自动化模板、标准化布局与统一化的设备平台,测试时长得以缩短,使该基地比同类部署提前三到四个月实现首次器械组装操作、提前一年以上具备首次注射器灌装能力。
Modular construction, particularly the offsite fabrication and integration of the 14,000-square-foot central utility plant (CUP), further reduced complexity and improved quality. Delivered as 25 pretested modules, the CUP allowed earlier commissioning of utilities and eliminated typical onsite congestion associated with high density mechanical construction.
模块化建造——尤其是 14,000 平方英尺中央公用工程站(CUP)的场外预制与集成——进一步降低了复杂性并提升了质量。CUP 以 25 个预测试模块交付,使公用工程得以更早调试,并消除了高密度机械施工常见的现场拥挤。
Execution was further enhanced by the extensive use of digital twin technology, enabling more than 250 days of virtual testing of automation logic, human-machine interface interactions, and start up sequences before equipment arrival. This innovation cut on floor testing time by roughly half.
执行过程还因大量使用数字孪生技术而进一步增强:在设备到场之前,对自动化逻辑、人机界面交互与开车顺序完成了 250 天以上的虚拟测试。这一创新把现场测试时间减少了约一半。
All scope was delivered, while maintaining industry leading safety performance.
全部范围均按计划交付,同时保持了行业领先的安全表现。
Supply partners and key participants: Engineer/Architect — Hanbury; Construction Manager — BE&K Building Group; HVAC Subcontractor — McCorvey Sheet Metal; Mechanical Contractor — Kirlin Way; Electrical Contractor — Code Electric, Inc.; Mechanical and Electrical Engineer — HIPP Design & Consulting, Inc.
供应伙伴与主要参与方:
· 业主/生产商:Eli Lilly and Company
· 工程与建筑设计:Hanbury
· 施工管理:BE&K Building Group
· 暖通分包:McCorvey Sheet Metal
· 机械承包:Kirlin Way
· 电气承包:Code Electric, Inc.
· 机电工程:HIPP Design & Consulting, Inc.
— 完 —
来源:小南AI实验室 · mp.weixin.qq.com